Sinphar Pharmaceutical Co.,Ltd.
TAI: 1734.TW0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Taiwan Stock Exchange
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Zhiwen Li
- Employees
- 984
- Headquarters
- Yilan City, Taiwan
- IPO year
- 2002
- Market cap
- NT$5.8B
- Website
- https://www.sinphar.com.tw
Loading 1734…
Loading profile data…Frequently asked questions about 1734
What does Sinphar Pharmaceutical Co.,Ltd. (1734.TW) do?
Sinphar Pharmaceutical Co.,Ltd., together with its subsidiaries, researches, develops, manufactures, and sells therapeutic drugs, health care foods, and medical beauty products in Taiwan and internationally. It produces anti-cancer pharmaceuticals, such as injections, solid reagents, and hormone reagents; and tablets, soft gel capsules and powde...
Where does 1734.TW trade?
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) trades on the Taiwan Stock Exchange.
What sector is 1734.TW in?
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Sinphar Pharmaceutical Co.,Ltd.?
Zhiwen Li is the chief executive officer of Sinphar Pharmaceutical Co.,Ltd. (1734.TW).
Where is Sinphar Pharmaceutical Co.,Ltd. headquartered?
Sinphar Pharmaceutical Co.,Ltd. is headquartered in Taiwan.
Does 1734.TW pay a dividend?
Yes — Sinphar Pharmaceutical Co.,Ltd. (1734.TW) paid a trailing twelve-month dividend of TWD 0.95 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 1734.TW go public?
Sinphar Pharmaceutical Co.,Ltd. (1734.TW) completed its initial public offering in 2002.